Novellia Secures $18 Million in Latest Series A Funding Round

Novellia secured $18 million in its latest Series A, adding another data point to the Healthcare & Life Sciences funding market.

Novellia Raises $18 million in Funding

Novellia is a Digital Health company focused on Build Patient-Controlled Health Data Network for Drug Development.

Investors Behind the Funding

The round was backed by undisclosed investors. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Novellia operates in Healthcare & Life Sciences. Novellia's Series A round shows investors are still backing digital health platforms with real scale narratives. At $18M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Build Patient-Controlled Health Data Network for Drug Development

Looking Ahead

Novellia Raises $18M Series A to Build Patient-Controlled Health Data Network for Drug Development

Source reference: original announcement/article.